Skip to content
  • RESEARCH
  • PUBLICATIONS
  • TEAM
  • LAB NEWS
  • CONTACT
  • RESEARCH
  • PUBLICATIONS
  • TEAM
  • LAB NEWS
  • CONTACT

© 2019

Weight Loss and/or Sulindac Mitigate Obesity-associated Transcriptome, Microbiome, and Protumor Effects in a Murine Model of Colon Cancer

Bowers LW, Glenny EM, Punjala A, Lanman NA, Goldbaum A, Himbert C, Montgomery SA, Yang P,
Roper J, Ulrich CM, Dannenberg AJ, Coleman MF, Hursting SD.

Weight Loss and/or Sulindac Mitigate Obesity-associated Transcriptome, Microbiome, and Protumor Effects in a Murine Model of Colon Cancer

Cancer Prev Res (Phila) 2022 Aug 1;15(8):481-495. PMID: 35653548

Tags
2022

Post navigation

Previous post CAUSE, EPIDEMIOLOGY, AND HISTOLOGY OF POLYPS AND PATHWAYS TO COLORECTAL CANCER
Recent Posts
  • Weight Loss and/or Sulindac Mitigate Obesity-associated Transcriptome, Microbiome, and Protumor Effects in a Murine Model of Colon Cancer
  • CAUSE, EPIDEMIOLOGY, AND HISTOLOGY OF POLYPS AND PATHWAYS TO COLORECTAL CANCER
  • SPECTROSCOPIC OPTICAL COHERENCE TOMOGRAPHY FOR CLASSIFICATION OF COLORECTAL CANCER IN A MOUSE MODEL
  • METABOLISM AND COLORECTAL CANCER
  • MIRROR MIRROR ON THE WALL, WHO IS THE FITTEST OF THEM ALL: A NOVEL PREDICTION MODEL FOR POSTOPERATIVE HEPATIC DECOMPENSATION IN PATIENTS WITH CIRRHOSIS
Archives
  • April 2023
  • January 2022
  • February 2020
  • January 2020
Categories
  • Publications
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
© 2025 Roper Labs. Created for free using WordPress and Colibri